Clinical outcomes of functional endoscopic sinus surgery in cystic fibrosis patients - a single centre experience
Rhinology Journal · 2024
DOI: 10.4193/rhin23.057 ↗Kurz gefasst
Fachartikel in der Zeitschrift Rhinology Journal, 2024. Verfasst von Y Devabalan und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otolaryngology, Charing Cross Hospital, Imperial College Healthcare NHS Trust, London, UK. Hauptthemen laut MEDLINE: Cystic Fibrosis, Endoscopy, Sinusitis, Rhinitis.
Abstract (Originalsprache)
Background
Endoscopic sinus surgery (ESS) is an established surgical option for cystic fibrosis (CF) patients with chronic rhinosinusitis that is refractory to conventional medical management. Objective and subjective evidence of benefit of ESS in this cohort of patients is currently conflicting in the literature. Methodology: A single center retrospective study was undertaken of all CF patients (transplanted and non-transplanted) over the age of 16 who underwent an ESS over a six-year period from 2015 to 2021. Patients on triple-therapy CFTR modulators were excluded. Data was collected on demographics, clinical management, and outcome measures. The objective outcome measures were lung function (%predicted FEV1), pulmonary exacerbations (total number of days of IV antibiotics- both ambulatory and in hospital). The subjective outcome measure was SNOT-22 scores preand 6 months post-operatively. A minimally clinical important difference (MCID) in SNOT-22 scores of 9 points was used.
Results
55 patients were included in our study, with a median age of 31 and 53% females. Median Lund-Mackay scores for the cohort was 13 (3- 24). There was a significant improvement in lung function at 1-year post-surgery, and a significant MCID reduction in SNOT-22 scores at 6 months post-surgery across the cohort. Sub-group analysis revealed a sustained MCID reduction in SNOT-22 scores in both lung-transplanted and native lung groups, and in patients with primary ESS or previous ESS. However, there was no post-operative pulmonary function improvement in lung transplanted patients and patients with previous ESS. There was no impact on the rate of pulmonary exacerbations across the cohort. 2 patients in the cohort died secondary to pulmonary disease.
Conclusions
There was a demonstrated clinical and symptomatic benefit of ESS in CF patients in this study. Stricter guidelines for indications for ESS need to be established with regards to CF patients who will undergo ESS in the future.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Otolaryngology, Charing Cross Hospital, Imperial College Healthcare NHS Trust, London, UK.
- Department of Otolaryngology, Charing Cross Hospital, Imperial College Healthcare NHS Trust, London, UK; The Royal Brompton Hospital, Royal Brompton and Harefield NHS Foundation Trust, London, UK.
Zitieren
APA
Devabalan, Y., Towning, R., Magill, J., Saleh, H., & Rennie, C. (2024). Clinical outcomes of functional endoscopic sinus surgery in cystic fibrosis patients - a single centre experience. Rhinology Journal. https://doi.org/10.4193/rhin23.057
Vancouver
Devabalan Y, Towning R, Magill J, Saleh H, Rennie C. Clinical outcomes of functional endoscopic sinus surgery in cystic fibrosis patients - a single centre experience. Rhinology Journal. 2024. doi:10.4193/rhin23.057
BibTeX
@article{Devabalan2024,
author = {Devabalan, Y and Towning, R and Magill, J and Saleh, H and Rennie, C},
title = {Clinical outcomes of functional endoscopic sinus surgery in cystic fibrosis patients - a single centre experience},
journal = {Rhinology Journal},
year = {2024},
doi = {10.4193/rhin23.057}
}
EUVIMED